DexCare Raises $50M in Series B Funding


DexCare, a Seattle WA-based intelligence company focused on healthcare access, raised $50M in Series B funding.

The round was led by Transformation Capital, with participation from Kaiser Permanente, Providence Ventures, Mass General Brigham, Define Ventures, Frist Cressey Ventures, and SpringRock Ventures.

The company intends to use the funds to accelerate growth with investments in product and technology innovation, customer experience, and recruiting talent.

Led by Derek Streat, CEO, DexCare provides a Platform-as-a-Service (PaaS) for health systems that intelligently orchestrates digital demand and health system capacity across all lines of care. The data-driven intelligence engine allocates, flexes and optimizes resources to meet both consumer demand and health system business goals—expanding the reach of health system service lines into a new, digital and on-demand consumer arena. The platform attracts and caters to high-value consumers by providing a fully-digitized, unified experience that routes consumers to the best care options while leveraging existing EMR, caregiver and brand investments.

In 2021, the company expanded its platform to power access across a variety of applications including:

  • Health systems: large, national health systems, mid-sized regionals, and academic centers
  • Care modalities: video, phone, in-person, on-demand, scheduled
  • Service lines: same-day care, urgent care, primary care, specialty care

Incubated at Providence, DexCare has closed two funding rounds totaling $71M to-date.